Oyster Point Pharma Inc (OYST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 09-2018 | 06-2018 | 12-2017 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -16,503 | -12,492 | -5,860 | -6,601 |
| Accounts payable and accrued liabilities | N/A | 758 | 1,528 | N/A |
| Other Working Capital | -734 | -662 | -692 | 846 |
| Other Operating Activity | 154 | -647 | -1,460 | 1,081 |
| Operating Cash Flow | $-17,083 | $-13,043 | $-6,484 | $-4,674 |
| Cash Flows From Investing Activities | ||||
| Investing Cash Flow | $0 | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | 0 | 0 | 0 | 26,175 |
| Financing Cash Flow | $0 | $N/A | $N/A | $26,175 |
| Beginning Cash Position | 22,311 | 22,311 | 22,311 | 810 |
| End Cash Position | 5,228 | 9,268 | 15,827 | 22,311 |
| Net Cash Flow | $-17,083 | $-13,043 | $-6,484 | $21,501 |
| Free Cash Flow | ||||
| Operating Cash Flow | -17,083 | -13,043 | -6,484 | -4,674 |
| Free Cash Flow | -17,083 | -13,043 | -6,484 | -4,674 |